DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

Information source: Solvay Pharmaceuticals
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hypertension; Type 2 Diabetes

Intervention: eprosartan/HCTZ (Drug)

Phase: N/A

Status: Completed

Sponsored by: Solvay Pharmaceuticals

Official(s) and/or principal investigator(s):
Global Clinical Director Solvay, Study Director, Affiliation: Solvay Pharmaceuticals

Summary

This study is to demonstrate the superiority of combination of eprosartan/HCTZ versus ramipril/HCTZ.

Clinical Details

Official title: A Multi-Center, Double-Blind, Randomized Study Comparing the Efficacy of Combination Therapy of Eprosartan Respectively Ramipril With Low-Dose Hydrochlorothiazide and Moxonidine on Blood Pressure Levels in Patients With Hypertension and Associated Diabetes Mellitus Type 2

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Primary outcome: Blood pressure reduction

Secondary outcome: Comparison of responder rates

Eligibility

Minimum age: 40 Years. Maximum age: 80 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- essential hypertension,

- diabetes type 2

Exclusion Criteria:

- severe cardiovascular disease,

- grade 3 hypertension,

- secondary hypertension,

- abnormal liver enzymes

Locations and Contacts

Site 26, Calgary, Canada

Site 27, Montreal, Canada

Site 30, Quebec, Canada

Site 31, Thornhill, Canada

Site 28, Vancouver, Canada

Site 29, Winnipeg, Canada

Site 39, Holbaek, Denmark

Site 38, Roskilde, Denmark

Site 40, Viborg, Denmark

Site 4, Anzin, France

Site 3, Blois, France

Site 10, Chemellier, France

Site 11, Cholet, France

Site 15, Cholet, France

Site 16, Cholet, France

Site 14, La Jubaudiere, France

Site 13, Le Mesnil-en-Vallee, France

Site 7, Murs-Erigne, France

Site 9, Saumur, France

Site 8, Segre, France

Site 12, St Pierre Montlim, France

Site 6, Thouars, France

Site 2, Tours, France

Site 5, Vieux Conde, France

Site 20, Bad Muenster, Germany

Site 22, Floersheim, Germany

Site 19, Kirweiler, Germany

Site 21, Lambrecht, Germany

Site 25, Lindau, Germany

Site 18, Lueneburg, Germany

Site 24, Lutherstadt, Germany

Site 17, Riesa, Germany

Site 23, Waldbrunn, Germany

Site 62, Bologna, Italy

Site 60, Napoli, Italy

Site 58, Padova, Italy

Site 59, Palermo, Italy

Site 63, Pavia, Italy

Site 61, Pisa, Italy

Site 64, Torino, Italy

Site 43, Alesund, Norway

Site 42, Bergen, Norway

Site 44, Horten, Norway

Site 41, Skedsmokorset, Norway

Site 55, Badajoz, Spain

Site 51, Badalona, Spain

Site 56, Barcelona, Spain

Site 57, Barcelona, Spain

Site 54, Ciudad Real, Spain

Site 53, Granada, Spain

Site 52, Madrid, Spain

Site 48, Angelholm, Sweden

Site 47, Goteburg, Sweden

Site 46, Helsingborg, Sweden

Site 45, Kristianstat, Sweden

Site 50, Malmo, Sweden

Site 49, Stockholm, Sweden

Site 33, Aberdeen, United Kingdom

Site 36, Bath, United Kingdom

Site 37, Liverpool, United Kingdom

Site 34, Manchester, United Kingdom

Site 32, Oldham, United Kingdom

Site 35, Rugby, United Kingdom

Additional Information

Starting date: October 2004
Last updated: January 29, 2009

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017